SYNTHESIS, CHARACTERIZATION, BIOLOGICAL EVALUATION AND DOCKING OF SOME NOVEL SUBSTITUTED 1, 3-THIAZINE DERIVATIVES
Keywords:Thiazine, Anticonvulsant, Antimicrobial activities, Molecular docking
Objective: Chalcones and their heterocyclic analogs represent an important class of small molecules which have a wide range of pharmacological activities. Therefore, in this study, synthesis and anticonvulsant and antimicrobial activities of some new 1, 3-thiazines have been extensively discussed.
Methods: The reaction mixture of 4-tert-butylcyclohexanone on Claisen-Schmidt condensation with various aromatic aldehydes in the presence of dilute sodium hydroxide afforded the corresponding chalcones. Further, these compounds were subjected to cocondensation with thiourea, in the presence of isopropanol, catalyzed by aqueous potassium hydroxide to form 4-aryl 8-arylidene-5, 6-dihydro-2-imino-6-methyl-4H, 7H-(1, 3) benzothiazines. The structures of the newly synthesized compounds have been established on the basis of their spectral analysis. The newly synthesized compounds have been tested for their biological screening. Antimicrobial activity by cup plate agar diffusion method and antiepileptic activity by pentylenetetrazole (PTZ) induced seizures model, using diphenyl hydantain as standard, and also they are subjected to molecular properties prediction, toxicity, drug-likeness, lipophilicity and solubility parameters determination were done by using Osiris program, Molsoft, Prototox and ALOGPS 2.1 software. The binding mode of the synthesized compounds with active protein site has been predicted using docking method.
Results: Most of the compounds have shown good anticonvulsant as well as antimicrobial activities, but it is less than the standard drugs. 1, 3-thiazines derivatives were more potent, and among them, compounds TB5 andTB7 were the most active compounds in these series; TB5 whichcontains isopropyl phenyl moiety, was shown moderate potent activity with onset of convulsion at 14.1 min and TB7 containing 3, 4, 5-trimethoxyphenyl substituents on the thiazine moiety was more potent as it has prolonged the onset of convulsions by 18.7 min. Whereas in the case of antimicrobial activity of the compounds, from the results we have observed that TB5 have been shown greatest antimicrobial activity in all the bacterial and fungal strains, TB2 also shown superior activity, the others have been shown good antimicrobial activity.
Conclusion: According to the activity studies, it is observed that the synthesis and antimicrobial as well as anticonvulsant activities of novel 1, 3-thiazine derivatives have been shown better activity. Moreover molecular docking results give an insight into how further modification of the lead compound can be carried out for higher inhibitory activity. In particular, compounds with electron withdrawing substituents along with lipophilic methoxyl and isopropyl groups were more potent.
Thomas L Lemke, David A Williams. Foye's principles of medicinal chemistry. Philadelphia, P A Lippincott Williams and Wilkins; 2008.
Greene SA, Thurmon JC. Xylazine a review of its pharmacology and use in veterinary medicine. J Vet Phar Ther 1988;11:295-313.
Seeling A, Oelschlager H, Rothley D. Important pharmaceutical-chemical characteristics of the central muscle relaxant chlormezanone. Pharmazie 2000;55:293-6.
Ravindar B, Srinivasa Murthy M, Afzal Basha Shaik. Design, facile synthesis and biological evaluation of novel 1,3-thiazine derivatives as potential anticonvulsant agents. Asian J Pharm Clin Res 2016;9:272-6.
Ravindar Bairam, Srinivasa Murthy M. Synthesis characterization and biological screening of some novel substituted 1,3-thiazine derivatives. Der Pharm Chem 2015;7:150-4.
Shaik K Yazdan, Gali V Sagar, Afzal B Shaik. Biological and synthetic potentiality of chalcones. J Chem Pharm Res 2015;7:829-42.
Rathore MM. Synthesis and antimicrobial activities of some bromo-substituted-1, 3-thiazines. Int J Res Pham Bio Sci 2013;4:59-62.
Silverstein R. Spectroscopic identification of organic compounds. 6th ed. John Wiley and Sons Inc, New York; 1991.
Ibadur R Siddiqui, Pravin K Singh. Novel one pot synthesis of 1, 3-dithiins and 1, 3-thiazines under microwave irradiation. Int J Chem 2007;46:499-504.
Tarik E Sayed Ali, Azza Mohammed, E Kazak. Synthesis and antimicrobial activity of some new 1,3-thiazoles, 1,3,4-thiadiazoles, 1,2,4-triazoles and 1,3-thiazines incorporating acridine and 1,2,3,4-tetrahydroacridine moieties. Eur J Chem 2010;1:23.
Srikanth Jupudi. Screening of in vitro anti-inflammatory activity of some newly synthesized 1,3-thiazine derivatives. Int J Res Pharm Chem 2013;3:213-20.
Vijay V Dabholkar, Sagar D Parab. 1, 3-Thiazines and 1, 3-pyrimidines derivatives and their biological evaluation for anti-inflammatory, analgesic and ulcerogenic activity. Hetero Lett 2011;1:176-88.
Udupi RH, Bhat AR, Jacob J. Synthesis and biological evaluation of some biphenyl ether and thiazine derivatives. Indian J Heterocycl Chem 2005;15:89.
Temple C, Wheeler GP, Comber RN, Elliot RD, Montgomery JA. Synthesis of potential anticancer agents, Pyrido[4,3-b][1,4]oxazines and pyrido[4,3-b][1,4]thiazines. J Med Chem 1983;26:1641.
Subbagh-El, Abadi HI, Khawad IE, Pashood K. Synthesis of 2,2-(1,4-phenylene)bis-3,4-dihydro-2H-1,3-thiazin-4-ones and their facile recyclization to 2,2-(1,4-phenylene)bis(pyrimidin-4-one) and 2,2-(1,4-phenylene)-bis-(thieno[2,3-d] pyrimidin-4(1H)-one) derivatives. Arch Pharm 1999;332:1148-54.
Roman Lesyk, Olena Vladzimirska, Serhiy Holota, Lucjusz Zprutko, Andrzej Gzella. New 5-substituted thiazolo[3,2-b][1,2,4] triazol-6-ones. Synthesis and anticancer evaluations. Eur J Med Chem 2007;42:641-8.
Wei Wang, Bing Zhao, Chao Xu, Wenpeng Wu. Synthesis and antitumor activity of the thiazoline and thiazine multi thioether. Int J Org Chem 2012;2:117-20.
Beauchamp, Benardeau, Hilpert, Wang. 2-Aminodihydro 1,3-thiazines as base 2-inhibitors. For the treatment of diabetes patent scope, World intellectual property organization; 2011. p. 165.
Zawisza. Syntheses and pharmacological analysis of new derivatives of tetra hydro-[1,3]-thiazine and 2-thiobarbituric acid. Nat-Cent Biot Inf 1981;29:235-48.
Nagihan B, Bedia KK, Salih G, Feyza A. Synthesis and anticonvulsant activity of some 2-pyrazolines derived from chalcones. Arabian J Chem 2013;44:1-9.
Keerthi Kumar B. Synthesis and biological evaluation of different thiazine derivatives. J Pharm Res 2011;4:274-5.
Vieira TM, Regitano-D'Arce MA. Ultraviolet spectrophotometric evaluation of corn oil oxidative stability during microwave heating and oven test. J Agric Food Chem 1999;47:2203-6.
Foks H. Synthesis, structure and biological activity of 1, 2, 4-triazolo-1,3-thiazine derivatives. Pharmaceutica 1992;47:770-3.
Bhusari PK, Khedekar PB, Umathe SN, Bahekar RH, Rama R. Synthesis of 8-bromo-9-substituted-1, 3-benzothiazolo-[5, 1-b]-1, 3, 4-triazoles and their anthelmintic activity. Indian J Heterocycl Chem 2000;69:275.
Al-Khamees HA, Bayomi SM, Kandil HA, El-Thahir K. Microwave assisted green chemical synthesis of novel spiro [indole-pyrido thiazines], a system reluctant to be formed under thermal conditions. Eur J Med Chem 1990;25:103.
Turaska Rao, Bhongade SL, More SM, Dongarwar AS, Shende VS, Pande VB. Effects of lippia nodiflora extract on motor coordination, exploratory behaviour pattern, locomotor activity, anxiety and convulsions on albino Mice. Asian J Pharm Clin Res 2011;4:133-Â¬8.
Vogel AI. Text Book of Practical Organic Chemistry. 4th ed. ELBS, London; 1986. p. 796.
Paxonikyan EG, Sirakanyan SN, Noravyan AS, Arzanunts EM, Paronikyan RG, Sarikisyan IS, et al. Synthesis of 8-benzylamino-1, 2-dihydro-10-oxo-2, 2, 5-trimethyl-4H-pyrano [4, 3, 4, 5] pyrido [3, 2-e]-1, 3-thiazine and its psychotropic activity. Pharm Chem J 1994;28:25-8.
Dimmock JR, Kandepu NM, Hetherington M, Quail JW, Pugazhenthi U, Sudom AM. Cytotoxic activities of Mannich bases of chalcones and related compounds. J Med Chem 1998;41:1014-26.
Harode R, Sharma TC. Reaction of chalcone dibromide with thiourea in the presence of potassium hydroxide. Indian J Chem 1988;27B:1144-5.
Lipnick RL, Cotruvo JA, Hill RN, Bruce RD, Stitzed KA, Walker AP. Comparison of the up and down conventional LD50 and fixed dose acute toxicity procedures. Food Chem Toxicol 1955;33:223-31.
OECD Guidelines for the testing of chemicals, revised draft guideline 2001;423:1-14.
Parameshwar Ravula, Harinadha Babu V, Manichandrika P, Ramana Chary N, Narendra Sharath Chandra JN. Microwave assisted synthesis, biological evaluation and docking studies of novel pyrazoline derivatives as potent anti-inflammatory and antibacterial agents. Int J Chem Sci 2016;14:769-82.
Ahmed R Ali, Eman R El-Bendary, Mariam A Ghaly, Ihsan A Shehata. Novel acetamido thiazole derivatives, synthesis and in vitro anticancer evaluation. Eur J Med Chem 2013;69:908-18.
Holtkamp M, Meierkord H. Cellular and molecular pathogenesis of type 1A diabetes. Mol Life Sci 2007;64:2023-41.
Yamashita H, Ohno K, Amada Y, Hattori H, Funatsu YO, Toya T. Pharmacological and physiological functions of the polyspecific organic cation transporters: OCT1, 2, and 3 (SLC22A1-3). J Pharm Exp Ther 2004;308:127-33.
Bax BD, Chan PF, Eggleston DS, Fosberry A, Gentry DR, Gorrec F, et al. Type IIA topoisomerase inhibition by a new class of antibacterial agents. Nature 2010;466:935-40.
Richard A, Friesner Jay L, Banks, Robert B Murphy, Thomas A Halgren, Jasna J Klicic, et al. Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy. J Med Chem 2004;47:1739-49.
Dongamanti Ashok, Kavitha Rangu, Velagapuri Hanumantha Rao, Srinivas Gundu, Ballu Srilata, Manga Vijjulatha. Medicinal Chemistry Research; 2016;25:501-14.
Hargrove TY, Kim K, De NazarÃ© Correia Soeiro M, Da Silva CF, Batista DD, Batista MM, et al. CYP51 structures and structure-based development of novel, pathogen-specific inhibitory scaffolds. Int J Parasitol: Drugs Drug Resist 2012; 2:178-86.
Rayko Becher, Stefan GR Wirsel. Fungal cytochrome P450 sterol 14 alpha-demethylase [CYP51] and azole resistance in plant and human pathogens. Appl Micro Biot 2012;95:825-40.
White P, Aberle H, Vincent JP. Signaling and adhesion activities of mammalian beta-catenin and plakoglobin in drosophila. J Cell Biol 1998;140:183-95.